NanoViricides Inc. (NNVC)

[changes_iv]

It has been 30 days from 60---any updates from your government?

Countdown to catastrophe: UN warns world has just 60 DAYS to stop Ebola outbreak

The organisation says the virus is 'running faster than us and it is winning the race' as it continues to ravage West Africa and spread across the globe

http://www.mirror.co.uk/news/world-news/countdown-catastrophe-un-warns-world-4441661

(Reuters) - Scientists across the United States say they cannot obtain samples of Ebola, complicating efforts to understand how the virus is mutating and develop new drugs, vaccines and diagnostics.

The problems reflect growing caution by regulators and transport companies about handling Ebola as well as the limited resources of West African countries which are struggling to help thousands of infected citizens.

Ten scientists from eight major research institutions contacted by Reuters reported they were unable to get Ebola samples in recent months.

http://www.reuters.com/article/2014/11/05/us-health-ebola-usa-research-exclusive-idUSKBN0IP1DZ20141105

Ebola accelerates in Sierra Leone with 900% higher transmission rate

(NaturalNews) Things have been relatively quiet on the Ebola front here in the U.S. this past week, with 11 days and counting (as of this writing) since the last confirmed case of the disease was announced. But the situation is hardly as rosy in Sierra Leone, where an Africa Governance Initiative (AGI) report says Ebola is now spreading at a 900 percent faster rate than two months ago.

In early September, the official number was 1.3 new cases of Ebola per day in Sierra Leone, one of the three "ground zero" countries that has been most ravaged by the virus. Now, that number has escalated to 12 new cases per day in the rural areas surrounding Freetown, the country's capital, representing a more than nine-fold increase.

http://www.naturalnews.com/047547_Ebola_transmission_rate_Sierra_Leone.html

Number of Ebola-affected orphans in Liberia triples; patients mysteriously 'disappearing'; epidemic out of control in 80% of country
Thursday, November 13, 2014 by: J. D. Heyes

As MailOnline further reported:

This is the brutal truth about the outbreak that has ravaged West Africa and reached the U.S., Spain, Germany, and the U.K: not only are huge numbers of carriers simply 'disappearing' from official figures, but the number of children left orphaned is at least three times the size of existing estimates.

http://www.naturalnews.com/047626_Ebola_epidemic_orphans_Liberia.html

(NaturalNews) Defying its own quack advice that the agency has been propagandizing for months, the CDC has now released a document on Ebola that admits the virus can spread through aerosolized droplets. The document, quietly released on the CDC website, also admits Ebola can contaminate surfaces such as doorknobs, causing infections to be spread through indirect means. [1]

Here's a backup source of the PDF just in case the CDC scrubs it:
http://www.naturalnews.com/files/infections-spread-by-air-or-droplets.pdf

In other words, the CDC is now admitting it lied all along and that Natural News was correct from day one when we warned you about indirect transmission routes of the Ebola virus. (The CDC has always insisted it could only spread via "direct contact.")

"Ebola is spread through droplets," the CDC document now reads. Mirroring exactly what I've been telling millions of people in my free audio course at www.BioDefense.com the CDC now says "A person might also get infected by touching a surface or object that has germs on it and then touching their mouth or nose."

Yeah, we know. In fact, everybody in the independent media has known this for months, while all those who watch mainstream media sources are just now realizing this because they've been repeatedly lied to by CDC and NIH spokespeople.

The CDC has offered no apology whatsoever for intentionally misleading the public up to this point. Apparently, lying to the public is such a common activity at the highest levels of the CDC that they don't think there's anything wrong with it.

http://www.naturalnews.com/047457_Ebola_transmission_CDC_quackery_aerosolized_particles.html

Ebola Virus Infection Treatment & Management
Author: John W King, MD; Chief Editor: Burke A Cunha, MD

Pharmacologic Therapy

Nucleoside analogue inhibitors of the cell-encoded enzyme S-adenosylhomocysteine hydrolase (SAH) have been shown to inhibit Zaire ebolavirus replication in adult BALB/c mice infected with mouse-adapted Ebola virus.[21] Inhibition of SAH indirectly inhibits transmethylation reactions required for viral replication. Treatment response was dose-dependent. When doses of 0.7 mg/kg or more every 8 hours were begun on day 0 or 1 of infection, mortality was completely prevented. Even when the drug was given on day 2, 90% survived.

Smith et al found that in rhesus macaques infected with a lethal dose of Ebola virus, treatment with interferon beta early after exposure led to a significant increase in survival time, though it did not reduce mortality significantly.[22] These findings suggest that early postexposure interferon-beta therapy may be a promising adjunct in the treatment of Ebola virus infection.

Passive immunity has been attempted by using equine-derived hyperimmune globulins and human-derived convalescent immune globulin preparations. In Ebolavirus -infected cynomolgus macaques, use of human recombinant interferon alfa-2b in conjunction with hyperimmune equine immunoglobulin G (IgG) delayed but did not prevent death.

Equine IgG containing high-titer neutralizing antibodies to Ebola virus protected guinea pigs and baboons but was not effective in protecting infected rhesus monkeys.

During the 1995 outbreak in Kikwit, DRC, human convalescent plasma was used to treat 8 patients with proven Ebola disease, and only 1 patient died. Subsequent studies could not demonstrate survival benefit conferred by convalescent plasma products. The survival of these patients suggests that passive immunity may be of benefit in some patients.

Four laboratory workers in Russia who had possible Ebola exposure were treated with a combination of a goat-derived anti-Ebola immunoglobulin plus recombinant human interferon alfa-2. One of these patients had a high-risk exposure and developed clinical evidence of Ebola virus infection. All 4 patients recovered.

A recombinant human monoclonal antibody directed against the envelope glycoprotein (GP) of Ebola virus has been demonstrated to possess neutralizing activity. This Ebola virus-neutralizing antibody may be useful in vaccine development or as a passive prophylactic agent.

DNA vaccines expressing either envelope GP or nucleocapsid protein (NP) genes of Ebola virus have been demonstrated to induce protection in adult mice exposed to the virus. These vaccines were administered by coating gold beads with DNA expressing the genes for either GP or NP, and they were delivered by skin particle bombardment using a PowderJect-XR gene gun. Both vaccines induced measurable antibody responses detected by enzyme-linked immunosorbent assay (ELISA) and induced cytotoxic T-cell immunity.

Other experimental therapies that use available drugs, though not approved by the US Food and Drug Administration (FDA) for treatment of Ebola virus infection, may be considered. Agents that may reduce mortality without directly effecting viral replication include activated protein C[2] and a recombinant nematode anticoagulant protein (NAP) that inhibits activated factor VII-tissue factor complex.[3] NAP resulted in attenuation of the coagulopathy associated with decreased fibrinolysis and fibrin deposition with a resultant decrease in the severity of the systemic inflammatory response syndrome.

In a rhesus macaque model of Ebola hemorrhagic fever, which carries a mortality approaching 100%, Geisbert et al administered recombinant nematode anticoagulant protein, a potent inhibitor of TF-initiated coagulation.[3] One third of the monkeys given the nematode anticoagulant protein survived a lethal dose of Ebola virus, whereas 16 of the 17 (94%) control animals died. This approach targeted the hemorrhagic disease component of the infection rather than the virus itself.

http://emedicine.medscape.com/article/216288-treatment

Doctor, Cured of Ebola, Released With Cheers, Hugs

http://www.nbcnews.com/storyline/ebola-virus-outbreak/doctor-cured-ebola-released-cheers-hugs-n246056

The Ebola virus is mutating in West Africa at an alarming rate. Has the NBC news acclaimed cure for the Ebola virus shipped to West Africa? If yes, what do mortality statistics tell us today? Lower or higher than 70%?